GLP-1 Drugs For Weight Loss Aren’t Cost-Saving Yet
Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...
Tyler Morning Telegraph1d
How do GLP-1s Boost Weight Loss, Heart Health?
These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways to help people lose ...
Hosted on MSN3d
FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes Treatment
The fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration ...
Healthline11d
Managing Type 2 Diabetes and Hormonal Imbalance
Many people with type 2 diabetes can manage their blood sugar levels with lifestyle changes, including exercise and nutrition ...
Medscape5d
The Glucagonostatic and Insulinotropic Effects of Glucagon-like Peptide 1 Contribute Equally to its Glucose-lowering Action
Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...
healthday10d
FDA Approves Zepbound for Sleep Apnea in Patients With Obesity
The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the ...
Medscape28d
Risk for Ischemic Optic Neuropathy From Glucagon-Like Peptide 1 Receptor Agonists Too Rare to be Detected
Patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) appear to have a very low incidence of nonarteritic anterior ischemic optic neuropathy (NAION) when appropriately ...
Nature4y
G-Protein-Coupled Receptors, Pancreatic Islets, and Diabetes
In addition to impaired insulin secretion, type 2 diabetic patients also have elevated levels of glucagon, which worsens hyperglycemia by increasing glucose production by the liver. Type 2 ...